Molecular Pharmacology Ltd (MLPH)

[e-ore]

MLPH company profile updated at Bloomberg/Business Week. Deal with DDC added

Shares Outstanding 111,553,740 a/o Aug 13, 2013
79% of O/S held by Pharmanet
There's no convertible debt or preferred stock.

DDC (Dermatology Development Corporation) owned by Perry Robins, MD. His stamp of approval on ThermaLIFE products bodes well for the future. Imo, of course :)

Perry Robins, MD:

http://www.skincancer.org/about-us/who-we-are/dr-perry-robins

From Bloomberg/Business Week:

"Molecular Pharmacology (USA) Limited, a development stage company, develops and commercializes pain and inflammation management products primarily in Australia and the United States. The company, through its subsidiary, Molecular Pharmacology Pty. Ltd., develops analgesic and anti-inflammatory molecule, known as Tripeptofen for the treatment of common every-day pain, and is available in various dosage forms, formulations, line extensions, and package configurations. It focuses on marketing its products through pharmaceutical distributors, and through collaborative dealings with companies in the United States and Europe. The company also has an agreement with Dermatology Development Corporation to develop and market a range of therapeutic, cosmetic, and cosmecutical products based on the ThermaLIFE product range and its active ingredient. The company is based in Perth, Australia. Molecular Pharmacology (USA) Limited is a subsidiary of PharmaNet Group Limited."